|
MechanismGlobo H inhibitors |
|
|
|
|
Drug Highest PhasePhase 3 |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Cardinal Health (Shanghai) Pharmaceutical Co., Ltd.
0 Patents (Medical) associated with Cardinal Health (Shanghai) Pharmaceutical Co., Ltd.
100 Deals associated with Cardinal Health (Shanghai) Pharmaceutical Co., Ltd.
100 Translational Medicine associated with Cardinal Health (Shanghai) Pharmaceutical Co., Ltd.